Back

CGM: global experts weigh in on the future of diabetes care

13.11.26
CGM: global experts weigh in on the future of diabetes care

Continuous glucose monitoring (CGM) is quickly changing the approach to diabetes management — a point echoed by leading global experts and specialized organizations.

Anne Peters (USC, former ADA President)
"CGM enables patients to see in real time how lifestyle affects their glucose levels making diabetes management more conscious and effective."

Real-world impact: higher patient engagement and improved adherence to treatment

American Diabetes Association (ADA)
The ADA Standards of Care highlight that CGM is recommended for most people with diabetes, including those who do not use intensive insulin therapy.

Real-world impact: market growth and an increase in technology adoption

Roy Beck (Jaeb Center for Health Research)
Studies show that CGM use lowers HbA1c levels and reduces time in hypoglycemia, especially in patients with type 1 diabetes.

Real-world impact: a decrease in complications and healthcare costs

International Diabetes Federation
It is noted that with the growing number of diabetes patients, CGM systems are becoming a key tool for scalable disease control at the health system level.

 Real-world impact: reduced burden on physicians and the ability to monitor patients remotely

What this means in real-world terms:
— data-based personalized therapy
— higher quality of life for patients
— reduced risks of complications
— growth of telemedicine
— scalability of healthcare solutions

Leading experts and organizations agree: CGM is no longer an innovation, but rather a new standard, and its role will only grow in the years ahead.

MLC is at the forefront of innovation! Join in!